+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cough Hypersensitivity Syndrome Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4899042
  • Report
  • November 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • MORE
The report on the global cough hypersensitivity syndrome treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global cough hypersensitivity syndrome treatment market to grow with a CAGR of 5.9% over the forecast period from 2019-2025. The study on cough hypersensitivity syndrome treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on cough hypersensitivity syndrome treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cough hypersensitivity syndrome treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cough hypersensitivity syndrome treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • Rising prevalence of chronic respiratory diseases worldwide
  • Growing chronic cough conditions
  • A surge in the number of smokers globally
2) Restraints
  • Limited efficacy and undesirable side effects of antitussives
3) Opportunities
  • A surge in research and development activities in the cough hypersensitivity syndrome treatment
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global cough hypersensitivity syndrome treatment market is segmented on the basis of drug class, and distribution channel.

The Global Cough Hypersensitivity Syndrome Treatment Market by Drug Class
  • Inhales Corticosteroids
  • Antitussive Agents
  • Short-acting Beta-2 Agonists
  • Anticholinergics
  • Proton Pump Inhibitors
  • Antihistamines
  • Other Drug Classes
The Global Cough Hypersensitivity Syndrome Treatment Market by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Company Profiles

The companies covered in the report include
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • F. Hoffmann-La Roche AG
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Johnson & Johnson Consumer Inc.
  • Vertex Pharmaceuticals, Inc.
  • Boehringer Ingelheim GmbH
  • Other Companies
What does this report deliver??
1. Comprehensive analysis of the global as well as regional markets of the cough hypersensitivity syndrome treatment market.
2. Complete coverage of all the segments in the cough hypersensitivity syndrome treatment market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global cough hypersensitivity syndrome treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Cough Hypersensitivity Syndrome Treatment Market Highlights
2.2. Cough Hypersensitivity Syndrome Treatment Market Projection
2.3. Cough Hypersensitivity Syndrome Treatment Market Regional Highlights

3. Global Cough Hypersensitivity Syndrome Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Class
3.4.2. Growth Matrix Analysis by Distribution Channel
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Cough Hypersensitivity Syndrome Treatment Market

4. Cough Hypersensitivity Syndrome Treatment Market Macro Indicator Analysis

5. Global Cough Hypersensitivity Syndrome Treatment Market by Drug Class
5.1. Inhales Corticosteroids
5.2. Antitussive Agents
5.3. Short-acting Beta-2 Agonists
5.4. Anticholinergics
5.5. Proton Pump Inhibitors
5.6. Antihistamines
5.7. Other Drug Classes

6. Global Cough Hypersensitivity Syndrome Treatment Market by Distribution Channel
6.1. Hospital Pharmacies
6.2. Retail Pharmacies
6.3. Online Pharmacies

7. Global Cough Hypersensitivity Syndrome Treatment Market by Region 2019-2025
7.1. North America
7.1.1. North America Cough Hypersensitivity Syndrome Treatment Market by Drug Class
7.1.2. North America Cough Hypersensitivity Syndrome Treatment Market by Distribution Channel
7.1.3. North America Cough Hypersensitivity Syndrome Treatment Market by Country
7.2. Europe
7.2.1. Europe Cough Hypersensitivity Syndrome Treatment Market by Drug Class
7.2.2. Europe Cough Hypersensitivity Syndrome Treatment Market by Distribution Channel
7.2.3. Europe Cough Hypersensitivity Syndrome Treatment Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market by Drug Class
7.3.2. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market by Distribution Channel
7.3.3. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market by Country
7.4. RoW
7.4.1. RoW Cough Hypersensitivity Syndrome Treatment Market by Drug Class
7.4.2. RoW Cough Hypersensitivity Syndrome Treatment Market by Distribution Channel
7.4.3. RoW Cough Hypersensitivity Syndrome Treatment Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Cough Hypersensitivity Syndrome Treatment Market
8.2. Companies Profiled
8.2.1. Merck & Co., Inc.
8.2.2. Pfizer, Inc.
8.2.3. GlaxoSmithKline plc
8.2.4. AstraZeneca plc
8.2.5. F. Hoffmann-La Roche AG
8.2.6. Teva Pharmaceutical Industries Ltd.
8.2.7. Novartis AG
8.2.8. Johnson & Johnson Consumer Inc.
8.2.9. Vertex Pharmaceuticals, Inc.
8.2.10. Boehringer Ingelheim GmbH
8.2.11. Other Companies

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • F. Hoffmann-La Roche AG
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Johnson & Johnson Consumer Inc.
  • Vertex Pharmaceuticals, Inc.
  • Boehringer Ingelheim GmbH
Note: Product cover images may vary from those shown
Adroll
adroll